Tag: #MethotrexateTherapy

Introduction: Morbidly adherent placenta (MAP), encompassing conditions like placenta accreta, increta, and percreta, poses severe risks to maternal health due to potential hemorrhage during delivery. A compelling case report from Latifa Hospital, Dubai, demonstrates the successful use of Methotrexate therapy to manage MAP conservatively—offering fertility preservation and minimizing surgical risk.Visit https://www.obstetricgynecoljournal.com for more groundbreaking research…